微博
加入微博一起分享新鲜事
登录
|
注册
140
Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1) https://www.mscare.org/genentechs-fenebrutinib-confirms-its-potential-as-first-and-only-btk-inhibitor-f
请登录并选择要私信的好友
300
Genentech's Fenebrutinib Confirms Its Potential as First and Only BTK Inhibitor for Relapsing and Primary Progressive MS in Third Positive Phase III Study (FENhance 1) https://www.mscare.org/genentechs-fenebrutinib-confirms-its-potential-as-first-and-only-btk-inhibitor-f
已选择
0
张，还能选择
1
张
来自互联网
赞一下这个内容
公开
分享
获取分享按钮
正在发布微博，请稍候
